XML 10 R21.htm IDEA: XBRL DOCUMENT v3.20.1
Note 14 - Risk Management and Derivatives
3 Months Ended
May 02, 2020
Notes to Financial Statements  
Derivative Instruments and Hedging Activities Disclosure [Text Block]

Note 14

Risk Management and Derivatives

 

In the normal course of business, the Company’s financial results are impacted by currency rate movements in foreign currency denominated assets, liabilities and cash flows as it makes a portion of its purchases and sales in local currencies.  The Company has established policies and business practices that are intended to mitigate a portion of the effect of these exposures.  The Company uses derivative financial instruments, primarily forward contracts, to manage its currency exposures.  These derivative financial instruments are viewed as risk management tools and are not used for trading or speculative purposes.  Derivatives entered into by the Company are designated as cash flow hedges of forecasted foreign currency transactions. 

 

Derivative financial instruments expose the Company to credit and market risk.  The market risk associated with these instruments resulting from currency exchange movements is expected to offset the market risk of the underlying transactions being hedged.  The Company does not believe there is a significant risk of loss in the event of non-performance by the counterparties associated with these instruments because these transactions are executed with major international financial institutions.  Credit risk is managed through the continuous monitoring of exposures to such counterparties. 

 

The Company’s hedging strategy uses forward contracts as cash flow hedging instruments, which are recorded in the Company's condensed consolidated balance sheets at fair value. The effective portion of gains and losses resulting from changes in the fair value of these hedge instruments are deferred in accumulated other comprehensive loss and reclassified to earnings in the period that the hedged transaction is recognized in earnings.

 

As of  May 4, 2019 and  February 1, 2020, the Company had forward contracts maturing through May 2020.  The Company had no forward contracts as of May 2, 2020.  The contract amounts in the following table represent the net notional amount of all purchase and sale contracts of a foreign currency. 

 

(U.S. $ equivalent in thousands)

 

May 2, 2020

   

May 4, 2019

   

February 1, 2020

 

Financial Instruments

                       

U.S. dollars (purchased by the Company’s Canadian division with Canadian dollars)

  $     $ 13,230     $ 3,963  

Euro

          12,134       1,251  

Chinese yuan

          2,858       2,355  

New Taiwanese dollars

          469        

Other currencies

          376       69  

Total financial instruments

  $     $ 29,067     $ 7,638  

 

The classification and fair values of derivative instruments designated as hedging instruments included within the condensed consolidated balance sheets as of May 2, 2020, May 4, 2019 and February 1, 2020 are as follows:

 

 

Asset Derivatives

 

Liability Derivatives

 

($ thousands)

Balance Sheet Location

 

Fair Value

 

Balance Sheet Location

 

Fair Value

 

Foreign Exchange Forward Contracts

                   
May 2, 2020 Prepaid expenses and other current assets       Other accrued expenses      
May 4, 2019 Prepaid expenses and other current assets     183   Other accrued expenses     459  

February 1, 2020

Prepaid expenses and other current assets

     

Other accrued expenses

    103  

 

For the thirteen weeks ended May 2, 2020 and May 4, 2019, the effect of derivative instruments in cash flow hedging relationships on the condensed consolidated statements of earnings was as follows:

 

   

Thirteen Weeks Ended

 

($ thousands)

 

May 2, 2020

   

May 4, 2019

 

Foreign Exchange Forward Contracts: Income Statement Classification Gains (Losses) - Realized

 

Gain Recognized in OCL on Derivatives

   

Loss Reclassified from Accumulated OCL into Earnings

   

(Loss) Gain Recognized in OCL on Derivatives

   

Loss Reclassified from Accumulated OCL into Earnings

 
                                 

Net sales

  $ 23     $     $ (99 )   $  

Cost of goods sold

    60             289       (22 )

Selling and administrative expenses

    33       (6 )     35       (149 )
 

Additional information related to the Company’s derivative financial instruments are disclosed within Note 15 to the condensed consolidated financial statements.